The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma

被引:10
|
作者
Park, Yeonhee [1 ]
Lee, Dahye [2 ]
Lee, Jeong Eun [2 ]
Park, Hee Sun [2 ]
Jung, Sung Soo [2 ]
Park, Dongil [2 ]
Kang, Da Hyun [2 ]
Lee, Song-, I [2 ]
Woo, Seong-Dae [2 ]
Chung, Chaeuk [2 ]
机构
[1] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Internal Med,Div Pulm & Crit Care Med, Seoul 34943, South Korea
[2] Chungnam Natl Univ, Coll Med, Dept Internal Med, Div Pulmonol & Crit Care Med, Daejeon 34134, South Korea
基金
新加坡国家研究基金会;
关键词
lung adenocarcinoma; matrix stiffness; PD-L1; YAP; HIPPO PATHWAY; TUMOR MICROENVIRONMENT; EXTRACELLULAR-MATRIX; EGFR-TKI; CANCER; METASTASIS; YAP/TAZ;
D O I
10.3390/cancers16030598
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Tumor development is often accompanied by abnormal extracellular matrix (ECM) remodeling and increased stiffness. A stiff ECM promotes mechanotransduction, and the predominant transcription factors implicated in this phenomenon are YAP/TAZ, beta-catenin, and NF-kappa B. We sought to investigate whether YAP acts as a critical mediator between matrix stiffness and PD-L1 in lung adenocarcinoma. We confirmed that YAP, PD-L1, and Ki-67, a marker of cell proliferation, increased as the matrix stiffness increased in vitro. Through YAP knockdown and overexpression in a stiff-matrix environment, we discovered that YAP expression levels have an impact on the expression of PD-L1 and Ki-67. This study highlights the critical role of YAP in linking the ECM to PD-L1.Abstract The extracellular matrix (ECM) exerts physiological activity, facilitates cell-to-cell communication, promotes cell proliferation and metastasis, and provides mechanical support for tumor cells. The development of solid tumors is often associated with increased stiffness. A stiff ECM promotes mechanotransduction, and the predominant transcription factors implicated in this phenomenon are YAP/TAZ, beta-catenin, and NF-kappa B. In this study, we aimed to investigate whether YAP is a critical mediator linking matrix stiffness and PD-L1 in lung adenocarcinoma. We confirmed that YAP, PD-L1, and Ki-67, a marker of cell proliferation, increase as the matrix stiffness increases in vitro using the lung adenocarcinoma cell lines PC9 and HCC827 cells. The knockdown of YAP decreased the expression of PD-L1 and Ki-67, and conversely, the overexpression of YAP increased the expression of PD-L1 and K-67 in a stiff-matrix environment (20.0 kPa). Additionally, lung cancer cells were cultured in a 3D environment, which provides a more physiologically relevant setting, and compared to the results obtained from 2D culture. Similar to the findings in 2D culture, it was confirmed that YAP influenced the expression of PD-L1 and K-67 in the 3D culture experiment. Our results suggest that matrix stiffness controls PD-L1 expression via YAP activation, ultimately contributing to cell proliferation.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma
    Sun, Xian
    Li, Chia-Wei
    Wang, Wei-Jan
    Chen, Mei-Kuang
    Li, Hui
    Lai, Yun-Ju
    Hsu, Jennifer L.
    Koller, Paul B.
    Chan, Li-Chuan
    Lee, Pei-Chih
    Cheng, Fang-Ju
    Yam, Clinton
    Chen, Gong-Yan
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (02): : 564 - 571
  • [42] Relationship between PD-L1 Expression and Epithelial Mesenchymal Transition in Adenocarcinoma of the Lung
    Kim, Sehui
    Kim, Moon-Young
    Koh, Jaemoon
    Go, Heounjeong
    Jeon, Yoon Kyung
    Chung, Doo Hyun
    MODERN PATHOLOGY, 2016, 29 : 473A - 473A
  • [43] Quantification of PD-L1 mRNA Expression in Lung Adenocarcinoma with EGFR mutation.
    Isobe, Kazutoshi
    Kakimoto, Atsushi
    Tochigi, Naobumi
    Kaburaki, Kyohei
    Makino, Takashi
    Otsuka, Hahjime
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Mikami, Tetsuo
    Shibuya, Kazutoshi
    Iyoda, Akira
    Homma, Sakae
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
    Ma, Ke
    Qiao, Yulei
    Wang, Hao
    Wang, Shuai
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [45] PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung
    Kim, Sehui
    Koh, Jaemoon
    Kim, Moon-Young
    Kwon, Dohee
    Go, Heounjeong
    Kim, Young A.
    Jeon, Yoon Kyung
    Chung, Doo Hyun
    HUMAN PATHOLOGY, 2016, 58 : 7 - 14
  • [46] Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
    Kang Li
    Jun Liu
    Lin Wu
    Yajie Xiao
    Jia Li
    Haijian Du
    Zhikun Zhao
    Chao Sun
    Yongtian Zhao
    Jie Yang
    Dongfang Wu
    Zhuxiang Zhao
    Bolin Chen
    Cancer Cell International, 22
  • [47] FGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression upregulation in lung squamous cell carcinoma
    Lu, Min
    Wang, Kaixuan
    Ji, Wenxiang
    Yu, Yongfeng
    Li, Ziming
    Xia, Weiliang
    Lu, Shun
    CELLULAR IMMUNOLOGY, 2022, 379
  • [48] Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
    Li, Kang
    Liu, Jun
    Wu, Lin
    Xiao, Yajie
    Li, Jia
    Du, Haijian
    Zhao, Zhikun
    Sun, Chao
    Zhao, Yongtian
    Yang, Jie
    Wu, Dongfang
    Zhao, Zhuxiang
    Chen, Bolin
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [49] PD-1 and PD-L1 Expression in Advanced Endometrial Adenocarcinoma
    Liu, A. Y.
    Lester, J.
    Laury, A.
    Cass, I.
    Rimel, B. J.
    Li, A. J.
    Karlan, B. Y.
    Walsh, C. S.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 209 - 209
  • [50] PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes
    Miyazawa, Tomoyuki
    Marushima, Hideki
    Saji, Hisashi
    Kojima, Koji
    Hoshikawa, Masahiro
    Takagi, Masayuki
    Nakamura, Haruhiko
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 25 (01) : 1 - 9